Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy

Godaly, Gabriela LU orcid ; Carlsson, Ola LU and Broman, Marcus (2016) In Clinical Kidney Journal 9(2). p.205-210
Abstract

Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (

Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
critically ill patients, CRRT, hypophosphataemia, intensive care medicine
in
Clinical Kidney Journal
volume
9
issue
2
pages
6 pages
publisher
Oxford University Press
external identifiers
  • pmid:26985370
  • wos:000386129600006
  • scopus:84963946824
ISSN
2048-8505
DOI
10.1093/ckj/sfv133
language
English
LU publication?
yes
id
d9a36a3d-8e11-4070-bd86-cbd3135a44ea
date added to LUP
2016-06-16 09:07:45
date last changed
2025-04-19 15:24:48
@article{d9a36a3d-8e11-4070-bd86-cbd3135a44ea,
  abstract     = {{<p>Background Although associated with severe clinical complications, phosphate remains a neglected ion. Additionally, phosphate balance during continuous renal replacement therapy (CRRT) is complex and multifunctional. The present retrospective study investigated the effects of phosphate-containing CRRT fluid on phosphate homeostasis. Methods We retrospectively analysed 112 patients treated with CRRT at Skane University Hospital, Sweden. The control group was treated with Hemosol® B0 (no phosphate; n = 36) as dialysis and replacement fluid, while the study group received Phoxilium® (phosphate; n = 76) as dialysis fluid and Hemosol® B0 as replacement fluid. Results Hypophosphataemia (</p>}},
  author       = {{Godaly, Gabriela and Carlsson, Ola and Broman, Marcus}},
  issn         = {{2048-8505}},
  keywords     = {{critically ill patients; CRRT; hypophosphataemia; intensive care medicine}},
  language     = {{eng}},
  month        = {{04}},
  number       = {{2}},
  pages        = {{205--210}},
  publisher    = {{Oxford University Press}},
  series       = {{Clinical Kidney Journal}},
  title        = {{Phoxilium® reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy}},
  url          = {{http://dx.doi.org/10.1093/ckj/sfv133}},
  doi          = {{10.1093/ckj/sfv133}},
  volume       = {{9}},
  year         = {{2016}},
}